Eisai Transfers Rights to Receive Royalties Outside of Japan for EZH2 Inhibitor Tazemetostat to Royalty Pharma
- Written by ACN Newswire - Press Releases

Tazemetostat is a first-in-class, oral EZH2 inhibitor discovered by Epizyme,...

Tazemetostat is a first-in-class, oral EZH2 inhibitor discovered by Epizyme,...

Annual compliance in Singapore should not be treated as a once-a-year administrative event. It is an ongoing governance system that depends on accurate records, timely filings, disciplined approvals...

For many businesses, intellectual assets are among the most valuable things they own, yet they're often the last to receive formal legal protection. A brand name or a proprietary process can represe...

shutterstock(Manthofana/Shutterstock)● Peminggiran warga dari konservasi hutan Lingga Isaq menjadi salah satu faktor yang memperparah dampak bencana.● Pertanian monokultur dan tambang emas...